Top Ranked Value Stocks to Buy for January 7th

MTG SBOW

Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 7th:

SilverBow Resources Inc. (SBOW - Free Report) : This energy company that explores and produces oil and gas has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3.9% over the last 60 days.

SilverBow Resources Inc. Price and Consensus

SilverBow has a price-to-earnings ratio (P/E) of 2.72 compared with 7.50 for the industry. The company possesses a Value Score of A.

SilverBow Resources Inc. PE Ratio (TTM)

American Outdoor Brands Corporation : This firearms manufacturer and seller has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 9% over the last 60 days.

American Outdoor Brands Corporation Price and Consensus

American Outdoor has a price-to-earnings ratio (P/E) of 17.77, compared with 23.70 for the industry. The company possesses a Value Score of B.

American Outdoor Brands Corporation PE Ratio (TTM)

Cardtronics PLC : This automated consumer financial services provider has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 12.6% over the last 60 days.

Cardtronics PLC Price and Consensus

Cardtronics has a price-to-earnings ratio (P/E) of 13.01, compared with 19.60 for the industry. The company possesses a Value Score of A.

Cardtronics PLC PE Ratio (TTM)

MGIC Investment Corporation (MTG - Free Report) : This provider of private mortgage insurance and ancillary services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.6% over the last 60 days.

MGIC Investment Corporation Price and Consensus

MGIC Investment has a price-to-earnings ratio (P/E) of 7.00, compared with 16.00 for the industry. The company possesses a Value Score of B.

MGIC Investment Corporation PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>